🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Systemic Lupus Erythematosus Nephritis

The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study NCT05538208Phase 219 sites📍 San Francisco📍 Aurora📍 Atlanta Children's Hospital Medical Center, Cincinnati · Tests: Mycophenolate Mofetil, Mycophenolate Mofetil A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1) NCT06557265Phase 1, Phase 219 sites📍 Little Rock📍 Tustin📍 Gainesville Nkarta, Inc. · Tests: NKX019, Fludarabine, Cyclophosphamide Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE) NCT06350110Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: CD19- BCMA CAR-T cells Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor NCT05508009Phase 1, Phase 21 site📍 Palo Alto Alice Bertaina · Tests: Cyclophosphamide 1200 mg/Kg, Fludarabine, Cyclophosphamide 100 mg/Kg, Total Body Irradiation, ATG Assessing Residual Inflammation and Macrophage Presence in Lupus Nephritis After 3 Months of Intensified Treatment With Prednisolone, Mycofenolate Mofetil and Voclosporin as Compared to Mycofenolate Mofetil and Prednisolone NCT07760480Phase 41 site📍 Amsterdam Academisch Medisch Centrum - Universiteit van Amsterdam (AM… · Tests: Kidney Biopsy, Voclosporin (LUPKYNIS), Blood, feces and urine sample collection, LupusPRO questionnaire, Mycophenolate … The Effect of Mycophenolate Mofetil and Cyclophosphamide on the Lymphocyte Subsets in Patients With Proliferative Lupus Nephritis NCT02954939NA1 site📍 Hong Kong The University of Hong Kong · Tests: MMF-MMF, CTX-AZA NK010 or NK042 in Combination With Rituximab for Refractory Systemic Lupus Erythematosus/Lupus Nephritis NCT06676631Phase 11 site📍 Guangzhou Guangdong Provincial People's Hospital · Tests: NK 010 or NK042, Rituximab Renal Arterial Resistive Index as a Noninvasive Biomarker of Disease Activity in Lupus Nephritis Patients NCT06631404n/a1 site📍 Sohag Sohag University · Tests: renal doppler A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis NCT07570862Phase 212 sites📍 Beverly Hills📍 Fontana📍 Fullerton Fate Therapeutics · Tests: FT819 The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment NCT07340463Phase 21 site📍 Nanjing Nanjing University School of Medicine · Tests: Glucocorticoids, belimumab, Telitacicept, Mycophenolate mofetil (MMF) CD19/BCMA CAR-T Cell Therapy for Refractory/Relapsed Lupus Nephritis NCT06785519EARLY Phase 11 site📍 Hangzhou He Huang · Tests: CD19/BCMA Lupus Nephritis Targeted CAR T-cells injection Monitoring Lupus Nephritis Through Urinary Extracellular Vesicles NCT06642402n/a4 sites📍 Kolding📍 Odense📍 Odense Kolding Sygehus · Tests: Kidney biopsy, Urinary extracellular vesicle testing, Autoimmunity in plasma Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN NCT06527872n/a7 sites📍 Baltimore📍 Charlotte📍 Columbus GlaxoSmithKline · Tests: None (Observational study) Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires NCT05567198n/a1 site📍 Bethesda National Institute of Arthritis and Musculoskeletal and Ski… Safety and Efficacy of PRG-2311 for Refractory Lupus Nephritis and IgG4-Related Disease NCT06497361EARLY Phase 11 site📍 Wuhan Tongji Hospital · Tests: PRG-2311 To Evaluate the Effects of Cevostamab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis NCT07629583Phase 12 sites📍 Toulouse📍 Seville Genentech, Inc. · Tests: Cevostamab, Tocilizumab Childhood-onset Lupus Nephritis Initial Glucocorticoid-dose Harmonization Trial (LIGHT Trial) NCT07719140Phase 48 sites📍 Beijing📍 Beijing📍 Chongqing Peking Union Medical College Hospital · Tests: High-dose prednisone, Low-dose prednisone VIBRANT: VIB4920 for Active Lupus Nephritis NCT05201469Phase 217 sites📍 La Jolla📍 Los Angeles📍 Orange National Institute of Allergy and Infectious Diseases (NIAI… · Tests: VIB4920, Placebo for VIB4920 CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus NCT06839976Phase 1, Phase 21 site📍 Philadelphia Children's Hospital of Philadelphia · Tests: CART19 Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders NCT06434363Phase 1, Phase 22 sites📍 Houston📍 Houston M.D. Anderson Cancer Center · Tests: Tafasitamab, Fludarabine phosphate, Cyclophosphamide, Tafasitamab and NK cells A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease NCT06308978Phase 121 sites📍 Beverly Hills📍 Fullerton📍 Irvine Fate Therapeutics · Tests: FT819, Fludarabine, Cyclophosphamide, Bendamustine Wellness & Workforce Solution for Lupus/Lupus Nephritis NCT06217107NA1 site📍 Atlanta Morehouse School of Medicine · Tests: Micro-learning content, Health360x app, Culturally congruent coaching KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis NCT03929887n/a6 sites📍 Chuncheon📍 Daegu📍 Seoul Seoul National University Hospital · Tests: Kidney Biopsy A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases NCT07115745Phase 128 sites📍 Boston📍 Durham📍 Camperdown Juno Therapeutics, Inc., a Bristol-Myers Squibb Company · Tests: BMS-986515, Fludarabine, Cyclophosphamide, Tocilizumab A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis NCT07328581Phase 24 sites📍 Chicago📍 Hawthorne📍 New Hyde Park iCell Gene Therapeutics · Tests: ICG318, BCMA-CD19-IL-15/IL-15 sushi Compound CAR T following lymphodepletion HEALTH Home Urinalysis Testing NCT07823478NA1 site📍 New York NYU Langone Health · Tests: Home Urine Testing CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH NCT06947460Phase 1, Phase 21 site📍 Beijing Beijing GoBroad Hospital · Tests: CD19-BCMA CAR-T cells infusion SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus NCT07523542Phase 1, Phase 21 site📍 Shenzhen Beijing Biotech · Tests: Autologous anti-CD19 CAR-T cells, intravenous single infusion at protocol-defined dose level (1 x 10^6 or 3 x 10^6 CAR-… Lupus Nephritis Care Pathway NCT07783152NA1 site📍 Durham Duke University · Tests: Lupus Nephritis (LN) Care Pathway Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis NCT05207358Phase 41 site📍 Bucharest Institutul Clinic Fundeni · Tests: Rituximab, Mycophenolate Mofetil, Cyclophosphamide, Corticosteroids
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy